Chandra Bhagat Pharma Limited

CBPL

INE07QQ01016

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:52 2024-04-19 am EDT			5-day change	1st Jan Change
114.8 ^INR	+12.58%		+0.04%	-1.88%

2023	Chandra Bhagat Pharma Limited Reports Earnings Results for the Half Year Ended September 30, 2023	CI
2023	Chandra Bhagat Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2023	CI

Chandra Bhagat Pharma Limited has filed an IPO in the amount of INR 102 million.

December 16, 2019 at 12:00 am EST

Chandra Bhagat Pharma Limited has filed an IPO in the amount of INR 102 million. Security Name: Equity Shares Security Type: Common Stock Securities Offered: 2,000,000 PriceRange: INR 51 Discount Per Security: INR 0.8976 Transaction Features: Regulation S; Rule 144A

Latest news about Chandra Bhagat Pharma Limited

Chandra Bhagat Pharma Limited Reports Earnings Results for the Half Year Ended September 30, 2023	Nov. 09	CI
Chandra Bhagat Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-22	CI
1,510,521 Equity Shares of Chandra Bhagat Pharma Limited are subject to a Lock-Up Agreement Ending on 28-FEB-2023.	23-02-27	CI
Chandra Bhagat Pharma Limited Reports Earnings Results for the Half Year Ended September 30, 2022	22-11-14	CI
Chandra Bhagat Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-05-26	CI
Chandra Bhagat Pharma Limited Announces Appointment of Rajni Dawani as Company Secretary	22-03-31	CI
Chandra Bhagat Pharma Limited Reports Earnings Results for the Half Year Ended September 30, 2021	21-11-13	CI
Chandra Bhagat Pharma Limited Reports Audited Earnings Results for the Six Months and Year Ended March 31, 2021	21-06-29	CI
4,034,535 Equity Shares of Chandra Bhagat Pharma Limited are subject to a Lock-Up Agreement Ending on 28-FEB-2021.	21-02-27	CI
Chandra Bhagat Pharma Limited Announces Audited Consolidated Financial Results for the Year Ended March 31, 2020	20-07-30	CI
Chandra Bhagat Pharma Limited has completed an IPO in the amount of INR 102 million.	20-02-11	CI
Chandra Bhagat Pharma Limited has filed an IPO in the amount of INR 102 million.	19-12-16	CI

Chart Chandra Bhagat Pharma Limited

Duration

Period

More charts

Company Profile

Chandra Bhagat Pharma Ltd is an India-based pharmaceutical company. The Company is engaged in the business of marketing pharmaceutical critical care and health care products. The Company is focused on marketing pharmaceutical formulations and products in the domestic and international market through its own distribution network and sales under its own brand. It focuses on Injection - IV (Intravenous) and IM (Intramuscular), tablets and capsules supplied to hospitals and health care center for critical diseases. The Company also deals in importing and supplying active pharmaceutical ingredients (API) and its intermediates. The Company also has its presence in the therapeutic categories for formulations such as anti-cancer (oncology), antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, antifungal, antiviral, pediatrics, cardiology, nephrology, and neurology. It is also engaged in promoting and marketing of API in India.

Sector

Pharmaceuticals

Calendar

2024-05-21 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
CHANDRA BHAGAT PHARMA LIMITED	-1.88%	9.21M
ELI LILLY AND COMPANY	+25.35%	672B
NOVO NORDISK A/S	+24.08%	550B
JOHNSON & JOHNSON	-6.24%	351B
MERCK & CO., INC.	+15.39%	317B
ABBVIE INC.	+7.09%	292B
ASTRAZENECA PLC	+3.26%	211B
NOVARTIS AG	+0.78%	203B
PFIZER, INC.	-10.39%	144B
AMGEN INC.	-7.41%	141B